Crossref
Cardiac Dysrhythmias After Rituximab in Lymphoma are Associated With Increased Mortality
Heart, Lung and Circulation · 2026-08 · 35 · S89
DOI: 10.1016/j.hlc.2026.07.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart, Lung and Circulation, 2026-08. Verfasst von J. Lobasso und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lobasso, J., Ornelas, M., Alfares, S., Butel-Simoes, L., Sverdlov, A., Ngo, D., Yu, J., & Bennetts, J. (2026). Cardiac Dysrhythmias After Rituximab in Lymphoma are Associated With Increased Mortality. Heart, Lung and Circulation, 35, S89. https://doi.org/10.1016/j.hlc.2026.07.033
Vancouver
Lobasso J, Ornelas M, Alfares S, Butel-Simoes L, Sverdlov A, Ngo D, et al. Cardiac Dysrhythmias After Rituximab in Lymphoma are Associated With Increased Mortality. Heart, Lung and Circulation. 2026;35:S89. doi:10.1016/j.hlc.2026.07.033
BibTeX
@article{Lobasso2026,
author = {Lobasso, J. and Ornelas, M. and Alfares, S. and Butel-Simoes, L. and Sverdlov, A. and Ngo, D. and Yu, J. and Bennetts, J.},
title = {Cardiac Dysrhythmias After Rituximab in Lymphoma are Associated With Increased Mortality},
journal = {Heart, Lung and Circulation},
year = {2026},
volume = {35},
pages = {S89},
doi = {10.1016/j.hlc.2026.07.033}
}
EUVIMED